Halbert Hargrove Global Advisors’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Halbert Hargrove Global Advisors's TEVA Position: Q3 2026 in Review
Halbert Hargrove Global Advisors sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2026, closing a stake of 15 shares — an estimated $508 sold.
Halbert Hargrove Global Advisors first reported a position in TEVA in Q4 2013 and held it in 4 quarters. The position peaked at $358K in Q1 2014. 598 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- Halbert Hargrove Global Advisors reported no remaining Teva Pharmaceutical Industries position as of Q3 2026 after selling out during the quarter.
- Halbert Hargrove Global Advisors sold 15 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $508.
- Halbert Hargrove Global Advisors first reported a position in Teva Pharmaceutical Industries in Q4 2013 and held it in 4 quarters.
- Halbert Hargrove Global Advisors's Teva Pharmaceutical Industries position peaked at $358K in Q1 2014.
- 598 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.
Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.